TABLE 1.
Clinical and laboratory variables for 11 patients who underwent endoscopic transpapillary gallbladder drainage (ETGBD)
| Case number | Age (years) | Sex | CRP (mg/dL) | WBC (/μL) | Period to ETGBD (days)* | Fever (days)† | Abdominal pain (days)‡ | Hospitalization (days) | Remarks |
|---|---|---|---|---|---|---|---|---|---|
| ETGBD successful | |||||||||
| 1 | 57 | Female | 0.2 | 8800 | 1.0 | 2.0 | 1.0 | 20.0 | – |
| 2 | 89 | Male | 0.2 | 8000 | 2.0 | 1.0 | 0.0 | 9.0 | – |
| 3 | 57 | Female | 2.3 | 6100 | 5.0 | 3.0 | 3.0 | 14.0 | – |
| 4 | 62 | Male | 3.1 | 13,300 | 0.0 | 1.0 | 1.0 | 8.0 | – |
| 5 | 60 | Male | 0.3 | 12,300 | 2.0 | 0.0 | 1.0 | 7.0 | – |
| 6 | 89 | Male | 0.2 | 8000 | 0.0 | 2.0 | 1.0 | 29.0 | – |
| 7 | 74 | Female | 31.7 | 9300 | 4.0 | 7.0 | 2.0 | 15.0 | Gallbladder cancer |
| Mean | 69.7 | – | 5.4 | 9400 | 2.0 | 2.3 | 1.3 | 14.6 | – |
| ETGB unsuccessful | |||||||||
| 8 | 60 | Male | 20.6 | 9700 | 3.0 | – | – | – | – |
| 9 | 62 | Male | 0.2 | 4200 | 0.0 | – | – | – | – |
| 10 | 69 | Male | 8.6 | 20,100 | 0.0 | – | – | – | – |
| 11 | 77 | Male | 14.2 | 9800 | 4.0 | – | – | – | Cystic duct perforation |
| Mean | 67 | – | 10.9 | 10,950 | 1.8 | – | – | – | – |
In ETGBD-unsuccessful patients, period to ETGBD, fever, abdominal pain and hospitalization were not applicable because ETGBD was not successful (and percutaneus transhepatic gallbladder drainage was performed).
*
Period to ETGBD is the period from admission to performance of ETGBD;
†
Fever was the duration of fever;
‡
Abdominal pain was the duration of abdominal pain. CRP C-reactive protein on admission; WBC White blood cell count on admission